Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Trial of Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies

NCT07565220 is registered in ClinicalTrials.gov with Sawa Ito, MD as lead sponsor.

NCT NCT07565220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07565220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Trial of Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
Lead sponsor
Sawa Ito, MD
Phase
Phase 1
Overall status
Recruiting
Start date
July 27, 2026
Completion date
November 1, 2030
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia, acute lymphocytic leukemia (all), acute myeloid leukemia (aml), myelodysplastic syndrome(mds), myeloproliferative neoplasm (mpn)